Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kendra Grubb

Surgery Atlanta, GA Medical Doctor

NPI 1265688006 CMS profile 57748

550 Peachtree St Ne Fl 6, Atlanta, GA 30308

Open in the dashboard

General payments

$374,119

511 records reported · program years 2019–2025

Research payments

$88,873

Paid to them · 84 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$387,247 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Kendra Grubb of Atlanta, GA is reported in the CMS Open Payments database as having received $374,119 across 511 general payments and $88,873 in research payments paid to them. Separately, studies naming them as principal investigator received $387,247 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,873 2
2024 General $45,781 66
2024 Research $2,173 4
2023 General $40,884 38
2023 Research $21,090 17
2022 General $56,601 91
2022 Research $17,141 33
2021 General $69,823 89
2021 Research $32,468 17
2020 General $72,195 71
2020 Research $7,308 11
2019 General $85,963 154
2019 Research $8,695 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kendra Grubb
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Kendra Grubb were reported at $2,873. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Kendra Grubb Surgery median Middle half National median
2019 $85,963 $253 $82–$1,521 $163
2020 $72,195 $131 $40–$706 $114
2021 $69,823 $168 $50–$904 $132
2022 $56,601 $224 $76–$1,218 $149
2023 $40,884 $253 $82–$1,255 $160
2024 $45,781 $279 $90–$1,381 $164
2025 $2,873 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $185,257 233 payments
  2. Medtronic Vascular, Inc. $123,644 160 payments
  3. Boston Scientific Corporation $35,443 44 payments
  4. Ancora Heart, Inc. $17,088 20 payments
  5. Opsens Inc. $2,350 2 payments
  6. CryoLife, Inc. $2,168 3 payments
  7. Abbott Laboratories $2,053 8 payments
  8. Edwards Lifesciences Corporation $1,583 23 payments
  9. Medela AG $1,500 1 payment
  10. W. L. Gore & Associates, Inc. $1,125 1 payment
  11. Other $1,908 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $234,008 126 payments
  2. Consulting Fee $69,817 29 payments
  3. Travel and Lodging $45,813 121 payments
  4. Food and Beverage $16,956 228 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $5,666 3 payments
  6. Grant $1,860 4 payments
Products named General payments · program years 2019–2025
  1. CoreValve Evolut Transcatheter Valve Systems $106,135 128 payments
  2. COREVALVE EVOLUT R $98,866 110 payments
  3. CoreValve Evolut Transcatheter Valve Systems $59,042 65 payments
  4. General - Therapies $15,443 11 payments
  5. GENERAL STRUCTURAL HEART $9,260 6 payments
  6. Avalus $5,750 1 payment
  7. GENERAL - STRUCTURAL HEART $4,721 6 payments
  8. AccuCinch $3,748 4 payments
  9. SavvyWire $2,350 2 payments
  10. General Therapies $1,679 6 payments
  11. Other $14,465 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $72,871 71 payments
  2. Medtronic Vascular, Inc. $16,003 13 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Thoracic Surgery: 42

Drug cost

$71

Median for Thoracic Surgery: $318

Branded share of claims

100%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 19 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$71,263

Medicare's payments for the services billed

Medicare patients

134

Average age 77

Services billed

199

70 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Heart failure 59%
Ischemic heart disease 51%
Arthritis 46%
Chronic kidney disease 44%
Atrial fibrillation 37%
Diabetes 36%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

595 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record